1.
VJHemOnc
@VJHemOnc
Check out our most recent MDS session, where you'll hear from leading experts who share some insights into the IC… twitter.com/i/web/status/1…
2.
VJHemOnc
@VJHemOnc
#Tandem23 only 6/54 countries in Africa have a BMT program - huge unmet need #HealthCareDisparities - talk by Dr… twitter.com/i/web/status/1…
Retweet of status by @BldCancerDoc
3.
4.
5.
6.
7.
VJHemOnc
@VJHemOnc
Want to find out more about the role of the innate immune system in MDS?
Tune in to our latest podcast to hear m… twitter.com/i/web/status/1…
Tune in to our latest podcast to hear m… twitter.com/i/web/status/1…
VJHemOnc
@VJHemOnc
We can't believe #ASH21 is already over! We loved hearing from you all this week on Twitter!
Don't forget to wat… twitter.com/i/web/status/1…
Don't forget to wat… twitter.com/i/web/status/1…
VJHemOnc
@VJHemOnc
#ASH21 Oral: Early Signals of Efficacy & Safety w/ Autologous CD5 CAR T Cells in pts w/ R/R T-Cell Lymphoma.
Bri… twitter.com/i/web/status/1…
Bri… twitter.com/i/web/status/1…
Retweet of status by @uroosaibrahim
VJHemOnc
@VJHemOnc
@KordastiL of @KingsCollegeLon discusses the role of the immune system in #MDS pathology & progression
Background… twitter.com/i/web/status/1…
Background… twitter.com/i/web/status/1…
VJHemOnc
@VJHemOnc
@VJHemOnc is excited to be the official media partner for the #TexasMPNWorkshop2021
19-20 Aug, 2021
We'll b… twitter.com/i/web/status/1…
19-20 Aug, 2021
We'll b… twitter.com/i/web/status/1…
8.
9.
10.
11.
VJHemOnc
@VJHemOnc
Last chance!
The post-EHA MDS Session with @VJHemOnc is about to begin!
Join us live for exclusive insights… twitter.com/i/web/status/1…
The post-EHA MDS Session with @VJHemOnc is about to begin!
Join us live for exclusive insights… twitter.com/i/web/status/1…
VJHemOnc
@VJHemOnc
Shout outs to our friend & outstanding colleague Dr Jessica Altman .@jaltmanmd Professor Altman is a world exper… twitter.com/i/web/status/1…
Retweet of status by @doctorpemm
VJHemOnc
@VJHemOnc
#ESHCML2021: Breaking News!
ESH iCMLF JOHN GOLDMAN Conference on #CML GOING VIRTUAL!
New dates: October 7-10 202… twitter.com/i/web/status/1…
ESH iCMLF JOHN GOLDMAN Conference on #CML GOING VIRTUAL!
New dates: October 7-10 202… twitter.com/i/web/status/1…
Retweet of status by @ESHaematology
VJHemOnc
@VJHemOnc
Idecabtagene vicleucel has become the first CAR T-cell therapy to receive FDA approval for relapsed/refractory… twitter.com/i/web/status/1…
...but wait! There's more!
1.
fakhright
@fakhright
astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat*
